OBJECTIVES: The objectives are to describe health outcomes and hospital resource use of children after tracheotomy and identify patient characteristics that correlate with outcomes and hospital resource use. PATIENTS AND METHODS: A retrospective analysis of 917 children aged 0 to 18 years undergoing tracheotomy from 36 children's hospitals in 2002 with follow-up through 2007. Children were identified from ICD-9-CM tracheotomy procedure codes. Comorbid conditions (neurologic impairment [NI], chronic lung disease, upper airway anomaly, prematurity, and trauma) were identified with ICD-9-CM diagnostic codes. Patient characteristics were compared with in-hospital mortality, decannulation, and hospital resource use by using generalized estimating equations. RESULTS: Forty-eight percent of children were <or=6 months old at tracheotomy placement. Chronic lung disease (56%), NI (48%), and upper airway anomaly (47%) were the most common underlying comorbid conditions. During hospitalization for tracheotomy placement, children with an upper airway anomaly experienced less mortality (3.3% vs 11.7%; P < .001) than children without an upper airway anomaly. Five years after tracheotomy, children with NI experienced greater mortality (8.8% vs 3.5%; P <or= .01), less decannulation (5.0% vs 11.0%; P <or= .01), and more total number of days in the hospital (mean [SE]: 39.5 [4.0] vs 25.6 [2.6] days; P <or= .01) than children without NI. These findings remained significant (P < .01) in multivariate analysis after controlling for other significant cofactors. CONCLUSIONS: Children with upper airway anomaly experienced less mortality, and children with NI experienced higher mortality rates and greater hospital resource use after tracheotomy. Additional research is needed to explore additional factors that may influence health outcomes in children with tracheotomy.
OBJECTIVES: The objectives are to describe health outcomes and hospital resource use of children after tracheotomy and identify patient characteristics that correlate with outcomes and hospital resource use. PATIENTS AND METHODS: A retrospective analysis of 917 children aged 0 to 18 years undergoing tracheotomy from 36 children's hospitals in 2002 with follow-up through 2007. Children were identified from ICD-9-CM tracheotomy procedure codes. Comorbid conditions (neurologic impairment [NI], chronic lung disease, upper airway anomaly, prematurity, and trauma) were identified with ICD-9-CM diagnostic codes. Patient characteristics were compared with in-hospital mortality, decannulation, and hospital resource use by using generalized estimating equations. RESULTS: Forty-eight percent of children were <or=6 months old at tracheotomy placement. Chronic lung disease (56%), NI (48%), and upper airway anomaly (47%) were the most common underlying comorbid conditions. During hospitalization for tracheotomy placement, children with an upper airway anomaly experienced less mortality (3.3% vs 11.7%; P < .001) than children without an upper airway anomaly. Five years after tracheotomy, children with NI experienced greater mortality (8.8% vs 3.5%; P <or= .01), less decannulation (5.0% vs 11.0%; P <or= .01), and more total number of days in the hospital (mean [SE]: 39.5 [4.0] vs 25.6 [2.6] days; P <or= .01) than children without NI. These findings remained significant (P < .01) in multivariate analysis after controlling for other significant cofactors. CONCLUSIONS:Children with upper airway anomaly experienced less mortality, and children with NI experienced higher mortality rates and greater hospital resource use after tracheotomy. Additional research is needed to explore additional factors that may influence health outcomes in children with tracheotomy.
Authors: J M Sherman; S Davis; S Albamonte-Petrick; R L Chatburn; C Fitton; C Green; J Johnston; R K Lyrene; C Myer; H B Othersen; R Wood; M Zach; J Zander; R Zinman Journal: Am J Respir Crit Care Med Date: 2000-01 Impact factor: 21.405
Authors: S C Bahng; S VanHala; V S Nelson; E A Hurvitz; D W Roloff; E A Grady; C C Lewis Journal: Arch Phys Med Rehabil Date: 1998-11 Impact factor: 3.966
Authors: Jeffrey B Killingsworth; John M Tilford; James G Parker; James J Graham; Rhonda M Dick; Mary E Aitken Journal: Pediatrics Date: 2005-03 Impact factor: 7.124
Authors: Jay G Berry; Kevin Blaine; Jayne Rogers; Sarah McBride; Edward Schor; Jackie Birmingham; Mark A Schuster; Chris Feudtner Journal: JAMA Pediatr Date: 2014-10 Impact factor: 16.193
Authors: Jay G Berry; Michael Glotzbecker; Jonathan Rodean; Izabela Leahy; Matt Hall; Lynne Ferrari Journal: Pediatrics Date: 2017-02-02 Impact factor: 7.124
Authors: Brian D Benneyworth; Achamyeleh Gebremariam; Sarah J Clark; Thomas P Shanley; Matthew M Davis Journal: Pediatrics Date: 2011-05-16 Impact factor: 7.124
Authors: Jay G Berry; Robert J Graham; David W Roberson; Lawrence Rhein; Dionne A Graham; Jing Zhou; Jane O'Brien; Heather Putney; Donald A Goldmann Journal: Arch Dis Child Date: 2010-06-03 Impact factor: 3.791
Authors: Shannon M Hudson; Martina Mueller; William H Hester; Gayenell S Magwood; Susan D Newman; Marilyn A Laken Journal: J Spec Pediatr Nurs Date: 2014-03-03 Impact factor: 1.260